Attached files
| file | filename |
|---|---|
| EX-31.1 - CERTIFICATION - Kyto Technology & Life Science, Inc. | kbph_ex311.htm |
| EX-31.2 - CERTIFICATION - Kyto Technology & Life Science, Inc. | kbph_ex312.htm |
| 10-K/A - AMENDMENT TO FORM 10-K - Kyto Technology & Life Science, Inc. | kbph_10ka.htm |
Section 1350 Certification
In connection with the Annual Report on Form 10-K/A of Kyto Biopharma Inc. (the “Company”) for the year ended March 31, 2010 as filed with the Securities and Exchange Commission (the “Report”), I, Georges Benarroch, Chief Executive Officer and principal financial and accounting officer, of the Company, certify, pursuant to 18 U.S.C. SS. 1350, as adopted pursuant to SS. 906 of the Sarbanes-Oxley Act of 2002, that:
|
1.
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and
|
|
2.
|
The information contained in the Report fairly presents, in all material respects, the financial conditions and results of operations of the Company.
|
||
|
|
/s/ Georges Benarroch
|
||
| August 26 , 2010 |
Georges Benarroch
|
||
|
Chief Executive Officer, principal executive officer, principal financial and accounting officer
|
|||
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.